BDX · Becton, Dickinson and Company
Healthcare NYQ United States bd.com ↗
BULLISH BUY
Val Gro Qua Mom Sta Cap P/SN/A P/E Fwd P/E12.51 PEG1.11 52W –  RSI Target$180.25 (+7.0%) Beta0.27 Div2.51%
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Medical Instruments & Supplies Franklin Lakes, United States 60,000 employees
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 69 Overbought · 100
Signal Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
2Bearish
0Neutral
▲ Double Bottom — Two lows ~$141.48 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$141.12 — bullish reversal confirmed
▲ Bull Flag — Breakout after +10% pole — bullish continuation
▼ Double Top — Two peaks ~$156.51 — bearish reversal confirmed
▼ Double Top — Two peaks ~$151.94 — bearish reversal confirmed

View overlays on the price chart via Chart tab → Pattern Overlays.

Next Earnings Aug 06, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +7.0%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
7
7
BuyHoldSell
Price Target Range
$180.25 +7.0% upside
Low $161 High $225
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
UBS Buy ● Initiate 2026-07-28
Evercore ISI Group Outperform ↔ Maintain 2026-07-06
Barclays Overweight ↔ Maintain 2026-05-11
Wells Fargo Equal-Weight ↔ Maintain 2026-05-08
TD Cowen Hold ↔ Maintain 2026-05-04
Piper Sandler Neutral ↔ Maintain 2026-04-17
Argus Research Buy ↔ Maintain 2026-03-23
Citigroup Buy ↔ Maintain 2026-02-11
JP Morgan Neutral ↔ Maintain 2026-02-10
Jefferies Buy ↔ Maintain 2026-02-10
RBC Capital Sector Perform ↔ Maintain 2026-02-10
Stifel Buy ↔ Maintain 2026-01-07
B of A Securities Neutral ↔ Maintain 2026-01-05
Morgan Stanley Overweight ↔ Maintain 2025-12-02
UBS 2026-07-28
Buy ● Initiate
Evercore ISI Group 2026-07-06
Outperform ↔ Maintain
Barclays 2026-05-11
Overweight ↔ Maintain
Wells Fargo 2026-05-08
Equal-Weight ↔ Maintain
TD Cowen 2026-05-04
Hold ↔ Maintain
Piper Sandler 2026-04-17
Neutral ↔ Maintain
Argus Research 2026-03-23
Buy ↔ Maintain
Citigroup 2026-02-11
Buy ↔ Maintain
JP Morgan 2026-02-10
Neutral ↔ Maintain
Jefferies 2026-02-10
Buy ↔ Maintain
RBC Capital 2026-02-10
Sector Perform ↔ Maintain
Stifel 2026-01-07
Buy ↔ Maintain
B of A Securities 2026-01-05
Neutral ↔ Maintain
Morgan Stanley 2025-12-02
Overweight ↔ Maintain
Profitability
Gross Margin 47.09%TTM
Op. Margin 14.74%TTM
ROE 6.67%TTM
Rev. Growth 5.20%YoY
Free Cash Flow 4.53BTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 71.60MRQ
Current Ratio 0.94MRQ
Cash 816.00MMRQ
Total Debt 17.28BMRQ
Net Debt MRQ
Income
Div. Yield 2.51%TTM
Annual Rate 4.20Fwd
Payout Ratio 72.95%TTM
Dividend History
Payout Ratio (TTM): 72.95%
DateAmount / ShareYield at Payment
2026-06-09 $1.0500 0.69%
2026-03-10 $1.0500 0.65%
2025-12-08 $0.8255 0.56%
2025-09-08 $0.8176 0.55%
2025-06-09 $0.8176 0.62%
2025-03-10 $0.8176 0.47%
2024-12-09 $0.8176 0.48%
2024-09-09 $0.7469 0.42%
2024-06-10 $0.7469 0.41%
2024-03-07 $0.7469 0.42%
2023-12-07 $0.7469 0.43%
2023-09-07 $0.7154 0.36%
2023-06-08 $0.7154 0.39%
2023-03-09 $0.7154 0.42%
2022-12-08 $0.7154 0.39%
2022-09-08 $0.6840 0.36%
2022-06-08 $0.6840 0.37%
2022-03-09 $0.6673 0.35%
2021-12-09 $0.6673 0.39%
2021-09-08 $0.6366 0.34%
2021-06-08 $0.6366 0.38%
2021-03-09 $0.6366 0.37%
2020-12-09 $0.6366 0.38%
2020-09-08 $0.6059 0.37%
2020-06-08 $0.6059 0.35%
2020-03-09 $0.6059 0.38%
2019-12-09 $0.6059 0.34%
2019-09-06 $0.5906 0.33%
2019-06-06 $0.5906 0.36%
2019-03-07 $0.5906 0.35%
2018-12-07 $0.5906 0.37%
2018-09-06 $0.5752 0.33%
2018-06-07 $0.5752 0.37%
2018-03-08 $0.5752 0.38%
2017-12-07 $0.5752 0.39%
2017-09-07 $0.5599 0.42%
2017-06-07 $0.5599 0.44%
2017-03-08 $0.5599 0.46%
2016-12-07 $0.5599 0.52%
2016-09-07 $0.5062 0.43%
How BDX Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market CapN/A
Enterprise Value62.86B
Trailing P/E29.44
Forward P/E12.51
PEG Ratio (5yr)1.11
Price/Sales (ttm)N/A
Price/Book (mrq)1.92
EV/Revenue2.83
EV/EBITDA10.21
Share Statistics
Avg Vol (3m)2.70M
Shares OutstandingN/A
Float274.69M
% Held by Insiders0.42%
% Held by Institutions101.24%
Short Ratio3.74
Short % of Float4.29%
Profitability
Gross Margin47.09%
Operating Margin (ttm)14.74%
Profit Margin5.12%
Return on Assets (ttm)4.38%
Return on Equity (ttm)6.67%
Income Statement
Revenue (ttm)22.23B
Revenue Growth (yoy)5.20%
Gross Profit (ttm)10.47B
EBITDA6.16B
Net Income (ttm)1.65B
Diluted EPS (ttm)5.72
EPS Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)816.00M
Total Debt (mrq)17.28B
Debt / Equity (mrq)71.60
Current Ratio (mrq)0.94
Book Value / Share87.58
Operating CF (ttm)3.83B
Free Cash Flow (ttm)4.53B
Trading & Dividends
Beta (5Y)0.27
50-Day MA150.32
200-Day MA154.76
Fwd Dividend Yield252.00%
Payout Ratio72.95%
Ownership Breakdown
Institutional 101.24% Insider 0.42%
Short Interest 4.29% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in BDX in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-07-27 FELD MICHAEL Officer Sale at price 157.13 per share. 75 $11,785
2026-07-01 MUHSIN BILAL Officer Stock Award(Grant) at price 0.00 per share. 14,342
2026-06-26 FELD MICHAEL Officer Sale at price 152.80 per share. 75 $11,460
2026-06-24 GARRISON MICHAEL DAVID Officer Sale at price 145.66 per share. 1,100 $160,226
2026-06-10 GARRISON MICHAEL DAVID Officer Sale at price 151.48 per share. 1,100 $166,628
2026-06-01 POLEN THOMAS E JR Chief Executive Officer Conversion of Exercise of derivative security at price 126.16 per share. 20,209 $2,549,567
2026-06-01 POLEN THOMAS E JR Chief Executive Officer Sale at price 146.35 per share. 2,764 $404,511
2026-06-01 MENZIUSO PETER Officer Stock Award(Grant) at price 0.00 per share. 14,258
2026-05-26 FELD MICHAEL Officer Sale at price 147.35 per share. 75 $11,051
2026-05-07 ROQUE VITOR Chief Financial Officer Stock Award(Grant) at price 0.00 per share. 1,721
2026-04-27 FELD MICHAEL Officer Sale at price 151.94 per share. 74 $11,244
2026-03-26 FELD MICHAEL Officer Sale at price 156.83 per share. 75 $11,762
2026-03-16 MINNIX LANESHA General Counsel Stock Award(Grant) at price 0.00 per share. 7,492
2026-03-02 SPIKNER PAMELA L Officer Stock Award(Grant) at price 0.00 per share. 931
2026-03-02 ROQUE VITOR Chief Financial Officer Stock Award(Grant) at price 0.00 per share. 931
2026-02-26 FELD MICHAEL Officer Sale at price 181.84 per share. 75 $13,638
2026-02-18 SCOTT BERTRAM LEE Director Sale at price 182.61 per share. 953 $174,027
2026-01-27 WRIGHT JACQUELINE Director Stock Award(Grant) at price 0.00 per share. 1,098
2026-01-27 BYINGTON CARRIE L Director Stock Award(Grant) at price 0.00 per share. 1,098
2026-01-27 HAYES GREGORY J Director Stock Award(Grant) at price 0.00 per share. 1,098
2026-01-27 WALDSTREICHER JOANNE Director Stock Award(Grant) at price 0.00 per share. 1,098
2026-01-27 HUFFINES ROBERT LUTHER Director Stock Award(Grant) at price 0.00 per share. 1,098
2026-01-27 HENDERSON JEFFREY WILLIAM Director Stock Award(Grant) at price 0.00 per share. 1,098
2026-01-27 BROWN WILLIAM M. Director Stock Award(Grant) at price 0.00 per share. 1,098
2026-01-27 JONES CHRISTOPHER IAN MONTAGUE Director Stock Award(Grant) at price 0.00 per share. 1,098
FELD MICHAEL Officer
Sale at price 157.13 per share.
2026-07-27 75 sh $11,785
MUHSIN BILAL Officer
Stock Award(Grant) at price 0.00 per share.
2026-07-01 14,342 sh
FELD MICHAEL Officer
Sale at price 152.80 per share.
2026-06-26 75 sh $11,460
GARRISON MICHAEL DAVID Officer
Sale at price 145.66 per share.
2026-06-24 1,100 sh $160,226
GARRISON MICHAEL DAVID Officer
Sale at price 151.48 per share.
2026-06-10 1,100 sh $166,628
POLEN THOMAS E JR Chief Executive Officer
Conversion of Exercise of derivative security at price 126.16 per share.
2026-06-01 20,209 sh $2,549,567
POLEN THOMAS E JR Chief Executive Officer
Sale at price 146.35 per share.
2026-06-01 2,764 sh $404,511
MENZIUSO PETER Officer
Stock Award(Grant) at price 0.00 per share.
2026-06-01 14,258 sh
FELD MICHAEL Officer
Sale at price 147.35 per share.
2026-05-26 75 sh $11,051
ROQUE VITOR Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-05-07 1,721 sh
FELD MICHAEL Officer
Sale at price 151.94 per share.
2026-04-27 74 sh $11,244
FELD MICHAEL Officer
Sale at price 156.83 per share.
2026-03-26 75 sh $11,762
MINNIX LANESHA General Counsel
Stock Award(Grant) at price 0.00 per share.
2026-03-16 7,492 sh
SPIKNER PAMELA L Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 931 sh
ROQUE VITOR Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 931 sh
FELD MICHAEL Officer
Sale at price 181.84 per share.
2026-02-26 75 sh $13,638
SCOTT BERTRAM LEE Director
Sale at price 182.61 per share.
2026-02-18 953 sh $174,027
WRIGHT JACQUELINE Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh
BYINGTON CARRIE L Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh
HAYES GREGORY J Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh
WALDSTREICHER JOANNE Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh
HUFFINES ROBERT LUTHER Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh
HENDERSON JEFFREY WILLIAM Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh
BROWN WILLIAM M. Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh
JONES CHRISTOPHER IAN MONTAGUE Director
Stock Award(Grant) at price 0.00 per share.
2026-01-27 1,098 sh